BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 14, 2009
 |  BC Week In Review  |  Company News  |  Deals

Biotecnol S.A., Digna Biotech, Roche deal

Biotecnol and partner Digna received exclusive rights to Roche's Genentech Inc. unit's patents covering cardiotrophin-1 (CT-1) proteins for use in certain liver indications. Genentech...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >